Your browser doesn't support javascript.
ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
Xiao, Li; Sakagami, Hiroshi; Miwa, Nobuhiko.
  • Xiao L; Department of Pharmacology, School of Life Dentistry at Tokyo, The Nippon Dental University, Tokyo 102-0071, Japan.
  • Sakagami H; Meikai University Research Institute of Odontology (M-RIO), Saitama 3500283, Japan.
  • Miwa N; Faculty of Life Sciences, Prefectural University of Hiroshima, Hiroshima 7270023, Japan.
Viruses ; 12(5)2020 04 28.
Article in English | MEDLINE | ID: covidwho-133592
ABSTRACT
Recently, the SARS-CoV-2 induced disease COVID-19 has spread all over the world. Nearly 20% of the patients have severe or critical conditions. SARS-CoV-2 exploits ACE2 for host cell entry. ACE2 plays an essential role in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance. ACE2 also protects organs from inflammatory injuries and regulates intestinal functions. ACE2 can be shed by two proteases, ADAM17 and TMPRSS2. TMPRSS2-cleaved ACE2 allows SARS-CoV-2 cell entry, whereas ADAM17-cleaved ACE2 offers protection to organs. SARS-CoV-2 infection-caused ACE2 dysfunction worsens COVID-19 and could initiate multi-organ failure. Here, we will explain the role of ACE2 in the pathogenesis of severe and critical conditions of COVID-19 and discuss auspicious strategies for controlling the disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Peptidyl-Dipeptidase A / Virus Internalization Limits: Humans Language: English Year: 2020 Document Type: Article Affiliation country: V12050491

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Peptidyl-Dipeptidase A / Virus Internalization Limits: Humans Language: English Year: 2020 Document Type: Article Affiliation country: V12050491